spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  hearing loss 

 HSMN NewsFeed - 22 Oct 2025
Oticon Introduces the World's Smallest Powerhouse: Oticon Intent(TM) miniBTE R with Two Fitting Levels
Devices Product Launch
 HSMN NewsFeed - 6 Oct 2023
Amgen Completes Acquisition of Horizon Therapeutics plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Mar 2023
Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 15 Feb 2023
Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL
Diagnostics
 HSMN NewsFeed - 20 Apr 2021
Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 17 Nov 2020
SafKan Health Announces FDA 510(k) Clearance for First-of-its-Kind OtoSet(TM) Ear Cleaning System
Devices FDA
 HSMN NewsFeed - 6 Jul 2020
Cochlear obtains FDA approval of Kanso 2 Sound Processor, first off-the-ear cochlear implant sound processor with direct smartphone connectivity
Devices FDA
 HSMN NewsFeed - 7 Apr 2020
FDA expedites approval of Cochlear's Remote Check solution for cochlear implants
Devices FDA Product Launch
 HSMN NewsFeed - 11 Dec 2019
FDA clears Cochlear's innovative new Osia(R) 2 hearing implant system
Devices FDA
 HSMN NewsFeed - 3 Sep 2019
Strekin AG Secures Financing to Complete Development of STR001 in Sudden Sensorineural Hearing Loss and to Prepare NDA Filing in Europe
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Jun 2019
FDA approves new cochlear implant with easier access to MRI and expanded connectivity ready for Google's direct streaming to Android smartphones
Devices FDA
 HSMN NewsFeed - 20 May 2019
Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss
Regenerative Medicine Venture Capital Personnel
 HSMN NewsFeed - 6 May 2019
Spiral Therapeutics Closes Series A Financing Totaling $5.6 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Jun 2018
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Regenerative Medicine Personnel
 HSMN NewsFeed - 5 Feb 2018
FDA Clears Oricula Therapeutics Investigational New Drug Application for Clinical Trials
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Sep 2017
Spiral Therapeutics Receives Positive IND Submission Guidance from FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Jul 2017
Cochlear Introduces the World's First Made-for-iPhone Cochlear Implant Sound Processor
Devices Product Launch
 HSMN NewsFeed - 17 May 2017
Sera Prognostics Appoints Nadia Altomare as Chief Commercial Officer
Diagnostics Personnel
 HSMN NewsFeed - 13 Jul 2016
Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 20 Jun 2016
Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated Genome Editing Treatment of MPS II
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Feb 2016
Amgen And UCB Announce Positive Top-Line Results From The Phase 3 Study Of Romosozumab In Postmenopausal Women With Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 8 Feb 2016
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Jan 2016
Otonomy Announces Publication Supporting Development of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Jan 2016
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 30 Nov 2015
OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Nov 2015
Otonomy Initiates Patient Enrollment in U.S. Phase 3 Clinical Trial of OTO-104 in Meniere's Disease
Biopharmaceuticals
 HSMN NewsFeed - 11 Nov 2015
OticPharma Appoints Dr. Catherine C. Turkel as Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2015
Third Rock Ventures Launches Decibel Therapeutics with $52 Million Series A Financing to Discover New Medicines to Protect, Repair and Restore Hearing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Apr 2015
ArmaGen Announces FDA Acceptance of IND Application for AGT-181 for the Treatment of Hurler Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Mar 2014
Cochlear Announces the FDA Approval and U.S. Launch of the First of Its Kind Cochlear(TM) Nucleus(R) Hybrid Implant System
Devices FDA Product Launch
 HSMN NewsFeed - 27 Feb 2014
Beltone Launches Beltone First, a Revolutionary Hearing Aid
Devices Product Launch
 HSMN NewsFeed - 24 Feb 2014
GN ReSound(R) Launches ReSound LiNX(TM), a Revolutionary Hearing Aid
Devices Product Launch
 HSMN NewsFeed - 19 Feb 2014
Parametric Sound Receives FDA Clearance for HyperSound
Devices FDA
 HSMN NewsFeed - 18 Dec 2013
Oticon Medical Receives FDA Clearance to Market New Ponto Plus Bone Anchored Sound Processors in Regular and Power Versions
Devices FDA
 HSMN NewsFeed - 2 Oct 2013
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
Devices Otolaryngology
 HSMN NewsFeed - 4 Sep 2013
Otonomy Completes $45.9 Million Series C Equity Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 10 Dec 2012
Nuron Biotech Acquires Commercial, Preventive Vaccine Meningitec(TM) from Pfizer
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 4 Dec 2012
Sophono Names Global Sales and Marketing Vice President
Devices Personnel
 HSMN NewsFeed - 25 Sep 2012
GenVec Announces Reduction in Workforce
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2012
GenVec Appoints Cynthia Collins as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2012
Sonitus Medical Closes $25 Million Series D Round Of Venture Capital Financing
Devices Venture Capital
 HSMN NewsFeed - 13 Dec 2011
GenVec President and Chief Executive Officer Announces Retirement
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2011
Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfield, MD as Chief Executive Officer
Diagnostics Venture Capital Personnel
 HSMN NewsFeed - 27 Jun 2011
Oticon Medical Secures FDA Clearance for Ponto Pro Power, World’s Most Powerful Fully Digital, Programmable Bone Anchored Power Processor
Devices FDA
 HSMN NewsFeed - 11 Mar 2011
Sonitus Medical Receives European CE Mark for SoundBite Hearing System
Devices Regulatory
 HSMN NewsFeed - 3 Feb 2011
Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2011
Sera Prognostics Closes $1.4 Million Series A-1 Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 8 Dec 2010
Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 16 Sep 2010
Lantos Technologies Closes on $1.6 Million Series A Financing to Support Development of World's First Real-Time 3D Ear Canal Scanning Technology
Devices Venture Capital
 HSMN NewsFeed - 30 Aug 2010
Otonomy Closes $38.5 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jun 2010
Otonomy Closes $10 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 May 2010
GenVec Announces Resignation of Mark Thornton as Senior Vice President, Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2010
Mayo Clinic Finds Stereotactic Radiosurgery is Successful for Most Patients with Large Acoustic Neuromas
Devices Neurosurgery Oncology
 HSMN NewsFeed - 30 Apr 2010
IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
Devices Ophthalmology
 HSMN NewsFeed - 17 Mar 2010
FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device
Devices FDA
 HSMN NewsFeed - 24 Feb 2010
Shire Provides Update on Biologics License Application (BLA) Filing for REPLAGAL(R) (agalsidase alfa) With the U.S. Food and Drug Administration (FDA)
Biopharmaceuticals
 HSMN NewsFeed - 17 Feb 2010
Otonomy Receives FDA Clearance to Initiate Clinical Trial in Patients with Meniere's Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Dec 2009
Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA)
Biopharmaceuticals
 HSMN NewsFeed - 8 Sep 2009
Cochlear Americas Announces FDA Approval of the Nucleus(R) 5 System, the Newest and Most Advanced Cochlear Implant System
Devices FDA
 HSMN NewsFeed - 10 Jul 2009
Cochlear Americas Announces FDA Clearance of the Cochlear(TM) Baha(R) BP100 Sound Processor, the Industry's First Programmable Bone Conduction Hearing Solution
Devices FDA
 HSMN NewsFeed - 26 Feb 2009
Clinical Evidence Grows in Support of CyberKnife Treatment for Intracranial and Extracranial Tumors
Devices Oncology
 HSMN NewsFeed - 5 Feb 2009
St. Jude Medical Announces U.S. Approval of Industry's First Connector System Designed to Simplify Implant Process for Cardiac Resynchronization Therapy Devices
Devices Cardiology FDA
 HSMN NewsFeed - 14 Jan 2009
St. Jude Medical Announces Japanese Approval of Atlas II ICD
Devices Cardiology Regulatory
 HSMN NewsFeed - 25 Jul 2008
Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants
Devices
 HSMN NewsFeed - 16 Jul 2008
Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
Biopharmaceuticals
 HSMN NewsFeed - 2 Jun 2008
Rexahn Pharmaceuticals Initiates Phase II Trial for Zoraxel(TM) to Treat Erectile Dysfunction
Biopharmaceuticals
 HSMN NewsFeed - 28 May 2008
Natus Medical Completes Acquisition of Sonamed
Devices Mergers & Acquisitions
 HSMN NewsFeed - 27 May 2008
Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Apr 2008
Latona Announces the Acquistion of Patent Rights and Orphan Drug Status to Novel Late Stage Drug Compound for Juvenile and Adult Rheumatoid Arthritis
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Apr 2008
Natus Medical to Acquire SonaMed
Devices Mergers & Acquisitions
 HSMN NewsFeed - 10 Apr 2008
American Academy of Otolaryngology-Head and Neck Surgery Approves Policy Statement on Micropressure Therapy for Meniere's Disease
Devices
 HSMN NewsFeed - 22 Feb 2008
Adherex Receives Orphan Drug Designation for ADH-1 in Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Feb 2008
Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 14 Jan 2008
Roche responds to announcement of 'IDEAL' hepatitis C trial results
Biopharmaceuticals
 HSMN NewsFeed - 2 Nov 2007
Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin
Biopharmaceuticals
 HSMN NewsFeed - 2 Nov 2007
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Biopharmacetuicals
 HSMN NewsFeed - 30 Oct 2007
Significant New Data on Roche's PEGASYS(R) and Hepatitis C Pipeline Compounds to be Featured at 58th Annual AASLD Meeting
Biopharmaceuticals
 HSMN NewsFeed - 19 Oct 2007
Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Oct 2007
Shire's ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Sep 2007
St. Jude Medical Announces FDA Approval of Company's First Radiofrequency Wireless ICD and CRT-D Heart Failure Devices
Devices Cardiology FDA
 HSMN NewsFeed - 18 Sep 2007
Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
Devices
 HSMN NewsFeed - 4 Sep 2007
Quark Pharmaceuticals Appoints New Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Aug 2007
IPSEN: Increlex(R) Receives Marketing Authorisation in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Jul 2007
Cochlear Americas Announces New Products for the Pediatric Market
Devices
 HSMN NewsFeed - 10 Jul 2007
OmniGuide(R) Launches the OtoBeam Flexible CO2 Laser Fiber Product Line for Otology
Devices
 HSMN NewsFeed - 14 Jun 2007
Shire's ELAPRASE(TM) (idursulfase) Approved by Health Canada for Treatment of Hunter Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 May 2007
St. Jude Medical Announces FDA Approvals of Current ICD and Promote CRT-D Heart Failure Devices
Devices Cardiology FDA
 HSMN NewsFeed - 8 May 2007
St. Jude Medical Announces European Approval of Company's First Wireless ICD and CRT-D Heart Failure Devices
Devices Cardiology Regulatory
 HSMN NewsFeed - 17 Apr 2007
Reclast(R) Receives US Approval as a Highly Effective Treatment for Patients with Paget's Disease of the Bone
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Mar 2007
European Committee Issued Positive Opinions to Extend Indication for PREVENAR to Include Pneumonia and Otitis Media
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Jan 2007
The European Commission Approves First and Only Enzyme Replacement Therapy for Hunter Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Jan 2007
Study Offers Hope of Long-Term Vertigo Relief for Meniere's Disease Patients
Devices
 HSMN NewsFeed - 19 Oct 2006
ELAPRASE(TM) (idursulfase) Receives Positive Opinion in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Oct 2006
Neurotechnology Industry Organization Launched to Advance Treatments for Brain and Nervous System Illnesses
Devices Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Sep 2006
Boston Scientific Announces FDA Approval of Harmony(TM) HiResolution(R) Bionic Ear System
Devices FDA
 HSMN NewsFeed - 12 Jul 2006
Mutual Pharmaceutical Company/AR Scientific Launches QUALAQUIN(TM) (quinine sulfate capsules USP, 324 mg)
Biopharmaceuticals
 HSMN NewsFeed - 28 Jun 2006
Cochlear Receives FDA Approval for the Next Generation of the Nucleus(R) Freedom(TM) Cochlear Implant System
Devices
 HSMN NewsFeed - 26 May 2006
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 42

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 42 additional stories matching:
hearing loss
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!